Zdrowie i gospodarka · 19/12/2025

FDA Clears DEXCHLORPHENIRAMINE MALEATE Oral Syrup for Continued Approval

The FDA has determined that DEXCHLORPHENIRAMINE MALEATE oral syrup was not withdrawn from sale due to safety or effectiveness concerns. This decision allows the FDA to continue approving ANDA applications for the product as long as they meet regulatory requirements.